Telesis Bio Inc reports results for the quarter ended in December - Earnings Summary

Telesis Bio

28/03/2024 21:29

* Telesis Bio Inc  TBIO.OQ  reported a quarterly adjusted
loss
of 23 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -28 cents.  The mean expectation of two analysts
for the quarter was for a loss of 22 cents per share. 
    * Revenue fell 26.3% to $6.98 million from a year ago;
analysts
expected $7.00 million. 
    * Telesis Bio Inc's reported EPS for the quarter was a loss
of 61
cents​.
    * The company reported a quarterly loss of $18.27 million.
    * Telesis Bio Inc shares had risen by 12.8% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Telesis Bio
Inc
is $4.00 

This summary was machine generated from LSEG data March 28 at
09:29 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.22          -0.23          Missed
 Sep. 30 2023      -0.30          -0.37          Missed
 Jun. 30 2023      -0.32          -0.28          Beat
 Mar. 31 2023      -0.37          -0.37          Met